A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Differentiating Chondrocytes from Peripheral Blood-derived Human Induced Pluripotent Stem Cells

8.5K views

DOI:

10.3791/55722

July 18th, 2017

In This Article

Erratum Notice

Important: There has been an erratum issued for this article. View Erratum Notice

Summary

We present a protocol to generate a chondrogenic lineage from human peripheral blood (PB) via induced pluripotent stem cells (iPSCs) using an integration-free method, which includes embryoid body (EB) formation, fibroblastic cells expansion, and chondrogenic induction.

Abstract

In this study, we used peripheral blood cells (PBCs) as seed cells to produce chondrocytes via induced pluripotent stem cells (iPSCs) in an integration-free method. Following embryoid body (EB) formation and fibroblastic cell expansion, the iPSCs are induced for chondrogenic differentiation for 21 days under serum-free and xeno-free conditions. After chondrocyte induction, the phenotypes of the cells are evaluated by morphological, immunohistochemical, and biochemical analyses, as well as by the quantitative real-time PCR examination of chondrogenic differentiation markers. The chondrogenic pellets show positive alcian blue and toluidine blue staining. The immunohistochemistry of collagen II and X staining is also positive. The sulfated glycosaminoglycan (sGAG) content and the chondrogenic differentiation markers COLLAGEN 2 (COL2), COLLAGEN 10 (COL10), SOX9, and AGGRECAN are significantly upregulated in chondrogenic pellets compared to hiPSCs and fibroblastic cells. These results suggest that PBCs can be used as seed cells to generate iPSCs for cartilage repair, which is patient-specific and cost-effective.

Introduction

Cartilage tissue has a very poor capacity for self-repair and regeneration. Various surgical interventions and biological treatments are used to restore cartilage and joint function, with unsatisfying results. The recent development of stem cell technology may change the entire cartilage repair field1. Various stem cells have been studied as seed cells, but human induced pluripotent stem cells (hiPSCs) appear to be the most promising choice, as they can provide many types of patient-specific cells without causing rejection reactions2. Furthermore, they can overcome the limited proliferative nature of adult cells and main....

Access restricted. Please log in or start a trial to view this content.

Protocol

The protocol for the generation of hiPSCs from PBCs can be found in our previous study5. The study was approved by the Institutional Review Board of our institution.

1. Embryoid Body (EB) Formation

  1. Make 50 mL of hiPSC medium: Knockout Dulbecco's Modified Eagle Medium (DMEM) supplemented with 15% knockout serum replacement (KSR), 5% fetal bovine serum (FBS), 1× nonessential amino acids, 55 μM 2-mercaptoethanol, 2 mM L-glutamine, and 8 ng/mL basic fibroblast growth factor (bFGF).
  2. Make 50 mLof EB formation medium: DMEM supplemented with 15% KSR, 5% FBS, 1x nonessential amino acids, 55....

Access restricted. Please log in or start a trial to view this content.

Results

Chondrogenic Differentiation of hiPSCs:

EB formation medium and basal culture medium were used to differentiate the hiPSCs into the mesenchymal lineage. A multi-step culture method was used (Figure 1). First, the hiPSCs were spontaneously differentiated via EB formation for 10 days (D10; Figure 2A). Second, cells outgrew from the EBs for another 10 days (D10+10). During th.......

Access restricted. Please log in or start a trial to view this content.

Discussion

Here, we provide a protocol to generate chondrocytes from PBCs via iPSCs. Because PBCs are more common and widely used in the clinical field, they are presented as a potential alternative for reprogramming. In this study, episomal vectors (EV) were utilized to reprogram PBCs into iPSCs, following the method established by Zhang et al.11. This integration-free approach does not involve integrating virus-associated genotoxicity, which is believed to have a broad effect in the clinical field.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors have nothing to disclose.

Acknowledgements

The authors wish to thank Xiaobin Zhang for his plasmid. We also thank Shaorong Gao and Qianfei Wang for their kind help during the experiment. This study is supported by the National Natural Science Foundation of China (No.81101346, 81271963, 81100331), the Beijing 215 high-level talent project (No.2014-3-025), and the Beijing Chao-Yang Hospital Fund (No. CYXX-2017-01), and the Youth Innovation Promotion Association of Chinese Academy of Sciences (Y.L.).

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
Knockout DMEMInvitrogen10829018Basal medium used for hiPSC culture and EB formation medium
Knockout Serum Replacement (KSR)Invitrogen10828028A more defined, FBS-free medium supplement used for hiPSC culture and EB formation medium
Fetal bovine serum (FBS)Hyclonesh30070.03Used for hiPSC culture and EB formation medium,offers excellent value for cell culture
Nonessential amino acidsChemiconTMS-001-CUsed as a growth supplement in all the cell culture medium, to increase cell growth and viability
L-glutamineInvitrogenTMS-002-CAn amino acid required for cell culture
Basic fibroblast growth factor (bFGF)Peprotech100-18BA cytokine used for sustaining the pluripotency and self-renewal of hiPSCs
DispaseInvitrogen17105041Used for hiPSC dissociation for subculture
DMEMGibcoC11960Basal medium used for MSC culture medium
0.1% gelatinMilliporeES-006-BUsed for cell attachment onto the dishes
0.25% trypsin/EDTAGibco25200072Used for cell dissociation
DPBSGibco14190250A balanced salt solution used for cell wash or reagent preparing
2-mercaptoethanolinvitrogen21985023Used as a growth supplement in all the cell culture medium.
ITSinvitrogen41400045Insulin, Transferrin, Selenium Solution.Used for chondrogenic differentiation.
Ascorbic acidSigma4403Known as vitamin C. It helps in active growth and has antioxidant property.
Sodium pyruvateGibco11360070Added to cell culture medium as an energy source in addition to glucose.
Transforming growth factor-beta 1PeprotechAF-100-21CA cytokine that regulate cell proliferation, growth and chondrogenic differentiation.
Rabbit polyclonal antibodies against Collagen IIAbcamab34712This antibody reacts with Type II collagens,which is specific for cartilaginous tissues.
Mouse monoclonal antibodies to Collagen XAbcamab49945This antibody reacts with Type X collagen,which is a product of hyperthrophic chondrotocytes.
PermountFisher ScientificSP15-100For mounting and long-term storage of slides
Toluidine blueSigma89640Used for proteoglycans detection.
Alcian blueAmresco#0298Used for glucosaminoglycans detection.
PapainSigmaP4762-25MGUsed to digest chondrogenic pellets.
Dimethylmethylene blueSigma341088-1GUsed to quantitate glycosaminoglyans
Chondroitin sulfate sodium salt from shark cartilageSigmaC4384-250MGUsed to draw the standard curve for sGAG content measurement.
Qubit dsDNA HS assay kitInvitrogenQ32851 (100)Used to determine DNA content
TRIzolInvitrogen15596018Used for RNA isolation from cells
Reverse Transcriptase SystemPromegaA3500Used to convert RNA into cDNA
SYBR FAST qPCR kit Master MixKapaKK4601Used for Real-time PCR

References

  1. Diekman, B. O., et al. Cartilage tissue engineering using differentiated and purified induced pluripotent stem cells. Proc Natl Acad Sci USA. 109 (47), 19172-19177 (2012).
  2. Park, I. H., et al. Disease-specific induced pluripotent stem cells. Cell

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Erratum


Formal Correction: Erratum: Differentiating Chondrocytes from Peripheral Blood-derived Human Induced Pluripotent Stem Cells
Posted by JoVE Editors on 1/01/1970. Citeable Link.

An erratum was issued for: Differentiating Chondrocytes from Peripheral Blood-derived Human Induced Pluripotent Stem Cells.

The corresponding author was updated from:

Yueying Li
yueyinglee2010@hotmail.com
Key Laboratory of Genomic and Precision Medicine, Beijing Institute of Genomics, Chinese Academy of Sciences

The corresponding author is now listed as:

Tie Liu
waterkins@163.com
Department of Orthopedics, Beijing Chao-Yang Hospital, Capital Medical University

Tags

Chondrocyte DifferentiationPeripheral Blood CellsEmbryoid Body FormationChondrogenic DifferentiationSerum Free CultureXeno Free CultureCollagen II StainingGlycosaminoglycan AnalysisChondrogenic Markers